Literature DB >> 4479613

What shall we do with the HBAg carrier?

.   

Abstract

Mesh:

Substances:

Year:  1974        PMID: 4479613      PMCID: PMC1612542     

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  8 in total

1.  Role of hepatitis-B antigen carriers in non-parenteral transmission of the hepatitis-B virus.

Authors:  J Heathcote; P Gateau; S Sherlock
Journal:  Lancet       Date:  1974-08-17       Impact factor: 79.321

2.  Exposure and immunity to hepatitis-B virus in a liver unit.

Authors:  W D Reed; C G Mitchell; A L Eddleston; W M Lee; R Williams; A J Zuckerman
Journal:  Lancet       Date:  1974-04-06       Impact factor: 79.321

3.  Assessment of activity in chronic active liver disease. Serum bile acids compared with conventional tests and histology.

Authors:  M G Korman; A F Hofmann; W H Summerskill
Journal:  N Engl J Med       Date:  1974-06-20       Impact factor: 91.245

4.  Australia antigen and antibody in 10,000 Danish blood-donors.

Authors:  O Banke; E Dybkjaer; E Nordenfelt; V Reinicke
Journal:  Lancet       Date:  1971-04-24       Impact factor: 79.321

5.  Postprandial serum bile acid for the detection of hepatobiliary disease.

Authors:  N Kaplowitz; E Kok; N B Javitt
Journal:  JAMA       Date:  1973-07-16       Impact factor: 56.272

6.  Familial clustering of hepatitis B infection.

Authors:  W Szmuness; A M Prince; R L Hirsch; B Brotman
Journal:  N Engl J Med       Date:  1973-11-29       Impact factor: 91.245

7.  The role of serum hepatitis virus in chronic liver disease.

Authors:  A M Prince; R L Hargrove; G H Jeffries
Journal:  Trans Assoc Am Physicians       Date:  1969

8.  Liver disease and cell-mediated immunity in hepatitis-associated antigen (HAA) carriers.

Authors:  T D Bolin; A E Davis; A G Liddelow
Journal:  Gut       Date:  1973-05       Impact factor: 23.059

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.